Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05846516
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-04-18
Brief Title:
A Study to Evaluate ATP150ATP152 VSV-GP154 and Ezabenlimab in Patients With KRAS G12DG12V Mutated PDAC KISIMA-02
Sponsor:
Organization:
Amal Therapeutics